-
Cowen Downgrades LDR Holding Following Zimmer Biomet Acquisition
Wednesday, June 15, 2016 - 2:46pm | 234Cowen downgraded LDR Holding Corp (NASDAQ: LDRH) to Market Perform from Outperform following its deal to be bought by Zimmer Biomet Holdings Inc (NYSE: ZBH) for $37 a share. "With shares of LDRH trading near the acquisition price, we are downgrading shares of LDRH to Market Perform and...
-
Pandemic Fears Could Be Major Catalyst For Cerus Drug, Cowen Says
Friday, January 29, 2016 - 11:55am | 266The share price of Cerus Corporation (NASDAQ: CERS) has declined 16.43 percent over the past month, to a low of $5.01 on Thursday. Cowen’s Joshua Jennings has maintained an Outperform rating on the company, with a price target of $8. An article in Transfusion has highlighted the...
-
Alcon, Inc.Acquires LenSx, Still In Negotiations With Novartis (ACL, NVS)
Wednesday, July 7, 2010 - 12:11pm | 176Alcon Inc. (NYSE: ACL) has signed an agreement to acquire LenSx Laser for $744 million. Alcon is a specialty company focused primarily on eye care; the company produces pharmaceuticals, surgical equipment, and consumer eye care products. Jefferies analysts Joshua Jennings and Anthony Petrone...
-
St. Jude Medical (STJ) Receives Department Of Justice Attention
Wednesday, May 5, 2010 - 2:03pm | 213Jefferies & Company analysts Peter J. Bye, Joshua Jennings and Anthony Petrone maintained their Buy rating for shares of St. Jude Medical, Inc. (NYSE: STJ), with a price target of $49 per share. The analysts said that the Department of Justice had given St. Jude Medical, Inc. a "civil...